CIWA-Ar Score

Calculate the CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) score to assess alcohol withdrawal severity using 10 standardized criteria with detailed breakdown, interpretation, and management recommendations.

Assess alcohol withdrawal severity using the CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) scale

Nausea/Vomiting — Ask: "Do you feel sick to your stomach? Have you vomited?"

Tremor — Arms extended and fingers spread apart

Paroxysmal Sweats — Observe for visible sweating

Anxiety — Ask: "Do you feel nervous?"

Agitation — Observe activity level

Tactile Disturbances — Ask: "Do you have itching, pins and needles, burning, numbness, or feel bugs crawling on your skin?"

Auditory Disturbances — Ask: "Are you more aware of sounds? Are they harsh? Do they frighten you? Are you hearing things that are not there?"

Visual Disturbances — Ask: "Does the light appear too bright? Is its color different? Does it hurt your eyes? Are you seeing things that are not there?"

Headache/Fullness in Head — Ask: "Does your head feel different? Does it feel like there is a band around your head?"

Orientation/Clouding of Sensorium — Ask: "What day is this? Where are you? Who am I?"

About This Calculator

The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) calculator helps healthcare professionals quantify the severity of alcohol withdrawal syndrome using a validated 10-item assessment scale. Originally developed by Shaw et al. in 1981 and revised by Sullivan et al. in 1989, the CIWA-Ar is the most widely used tool for objectively measuring alcohol withdrawal symptoms in clinical settings worldwide.

The scale evaluates 10 symptom domains: nausea and vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache or fullness in head, and orientation or clouding of sensorium. Nine items are scored from 0 (none) to 7 (extremely severe), while the orientation item is scored from 0 (oriented) to 4 (disoriented to place or person), yielding a maximum total score of 67.

Competent nurses can complete the CIWA-Ar assessment in less than two minutes, making it an efficient tool for serial monitoring of patients undergoing alcohol withdrawal. Research has shown that symptom-triggered management using the CIWA-Ar protocol results in decreased use of benzodiazepines and shorter treatment duration compared to fixed-dose regimens.

Regional Notes

United States: The CIWA-Ar is widely adopted in US hospitals as the standard of care for alcohol withdrawal management. The American Society of Addiction Medicine (ASAM) recommends symptom-triggered protocols using the CIWA-Ar. Treatment typically begins with benzodiazepines when scores reach 8-10, with ICU consideration for scores above 20.

United Kingdom: NICE guidelines (CG100) recommend using a validated tool like CIWA-Ar for monitoring alcohol withdrawal. The UK typically uses a symptom-triggered approach with chlordiazepoxide as the preferred benzodiazepine, with dosage adjusted based on CIWA-Ar scores.

India: CIWA-Ar is increasingly used in Indian hospital settings for managing alcohol withdrawal. Treatment protocols may vary between institutions, but benzodiazepines (typically diazepam or lorazepam) remain the mainstay of pharmacotherapy. The scale is used across both government and private healthcare facilities.

Frequently Asked Questions

What is the CIWA-Ar score and what does it measure?

The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol, Revised) is a validated 10-item scale that quantifies the severity of alcohol withdrawal syndrome. It measures nausea/vomiting, tremor, paroxysmal sweats, anxiety, agitation, tactile disturbances, auditory disturbances, visual disturbances, headache, and orientation. Each item is scored 0-7 (except orientation which is 0-4), with a maximum total score of 67.

How is the CIWA-Ar score interpreted for clinical management?

A CIWA-Ar score below 10 indicates minimal withdrawal and pharmacotherapy is not typically indicated. Scores of 10-19 suggest mild to moderate withdrawal requiring clinical judgment for pharmacotherapy. Scores of 20 or higher indicate severe withdrawal where pharmacotherapy (typically benzodiazepines) should be initiated, and ICU admission may be necessary due to risk of seizures and delirium tremens.

Who developed the CIWA-Ar scale and when?

The original CIWA scale was developed by Shaw et al. in 1981 with 15 items. It was revised and shortened to 10 items by Sullivan, Sykora, Schneiderman, Naranjo, and Sellers in 1989, becoming the CIWA-Ar (revised version) published in the British Journal of Addiction. The revised scale retains clinical validity and reliability while being more efficient to administer.

How long does it take to administer the CIWA-Ar assessment?

A competent nurse or healthcare professional can complete the CIWA-Ar assessment in less than two minutes. The scale consists of 10 observable and interview-based items covering gastrointestinal symptoms, autonomic hyperactivity, neuromuscular irritability, perceptual disturbances, and cognitive function.

What medications are used when CIWA-Ar score indicates pharmacotherapy is needed?

Benzodiazepines are the first-line treatment for alcohol withdrawal syndrome. Commonly used benzodiazepines include diazepam (Valium), lorazepam (Ativan), and chlordiazepoxide (Librium). Treatment typically follows symptom-triggered protocols where medication is administered when CIWA-Ar scores reach 8-10, with standing or as-needed dosing for scores 10-20. ICU transfer may be considered for scores above 20.

What conditions can mimic or coexist with alcohol withdrawal?

Several conditions can mimic or coexist with alcohol withdrawal syndrome, including drug overdose, intracranial hemorrhage, traumatic brain injury, infection such as meningitis, metabolic derangements like hypoglycemia or electrolyte imbalances, hepatic failure, and gastrointestinal bleeding. Additional testing may be necessary to rule out alternative diagnoses, especially if the presentation includes altered mental status or fever.

Is the CIWA-Ar scale used in clinical trials?

Yes, the CIWA-Ar scale is frequently used as a validated outcome criterion in clinical trials involving alcohol withdrawal syndrome. Its standardized scoring system allows researchers to objectively measure and compare treatment efficacy across different pharmacotherapeutic interventions for alcohol withdrawal.

Can the CIWA-Ar be used for patients already on benzodiazepines?

Yes, the CIWA-Ar can be used to monitor patients who are already receiving benzodiazepine therapy. Serial CIWA-Ar assessments help guide ongoing medication dosing, allowing clinicians to titrate benzodiazepine administration based on symptom severity. The goal is to achieve symptom control while minimizing over-sedation and reducing total benzodiazepine exposure.